M11.28
Other chondrocalcinosis, vertebrae
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis of the vertebrae, classified under ICD-10 code M11.28, is a condition characterized by the abnormal deposition of calcium crystals within the cartilage of the spinal vertebrae. This condition is a subset of chondrocalcinosis, commonly known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. While chondrocalcinosis can affect various joints and tissues, its occurrence within the vertebrae can influence spinal health and function. The condition may sometimes be asymptomatic or may lead to symptoms related to spinal discomfort and mobility issues.
Causes & Symptoms
Clinical Causes: Age-related degeneration leading to increased calcium crystal deposits Genetic predisposition to CPPD crystal formation Trauma or injury to the spine Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Previous joint or tissue inflammation Degenerative disc disease
Key Symptoms: Localized back pain or stiffness Reduced flexibility or range of motion in the affected spinal segment Radiculopathy (nerve root pain) if nerve roots are compressed Swelling or tenderness around the affected vertebral areas In some cases, no noticeable symptoms; the condition is discovered incidentally during imaging tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chondrocalcinosis of the vertebrae involves a combination of clinical evaluation and imaging studies. X-rays are typically the first step, revealing calcified deposits within the cartilage of the vertebrae. Advanced imaging techniques such as CT scans or MRI may provide more detailed visualization, especially if nerve involvement or other spinal pathology is suspected. Laboratory tests to measure calcium levels or identify associated metabolic disorders may be recommended. A definitive diagnosis often comes from tissue analysis demonstrating CPPD crystal deposits, although this is rarely performed solely for this condition.
Treatment Protocols: Management of chondrocalcinosis of the vertebrae aims at alleviating symptoms and preventing further joint or tissue damage. Treatment options include: - Pain management with NSAIDs or acetaminophen - Corticosteroid injections to reduce inflammation - Physical therapy to improve flexibility and support the spinal muscles - Addressing underlying metabolic or systemic conditions - Lifestyle modifications to reduce stress on the spine such as weight management and ergonomic adjustments In cases where nerve compression or significant structural problems occur, surgical intervention might be considered to decompress nerves or stabilize the spine. Since the disease process can be chronic, ongoing monitoring and supportive care are essential.
Clinical Advice & FAQs
Billing Guidance
Is M11.28 a billable ICD-10 code?
Yes, M11.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.28?
Clinical documentation must specify the nature of Other chondrocalcinosis, vertebrae and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
